Years of American-led investment into AIDS programs has reduced ... yearly injectable could end HIV, as studies published last year showed that the drug from pharmaceutical maker Gilead was 100% ...

During his 36-year career at Cancer Center, Michael Emerman, PhD, made fundamental discoveries about HIV, the retrovirus that causes AIDS. He co-founded the field of paleovirology and considers ...

The $4 billion that the United States pledged for the global HIV response for 2025 disappeared virtually overnight in January ...

The Joint United Nations Programme on HIV/AIDS (UNAIDS) warns that the global AIDS response is in crisis after a major funding collapse at the start of 2025 threatens to reverse decades of ...

Years of American-led investment into AIDS programs has reduced the number of people killed by the disease to the lowest ...

Politics and anxiety drive Part One, subtitled “Millennium Approaches,” and Part Two, “Perestroika,” diverges into the ...

UNAIDS emphasizes that every dollar invested in the HIV response not only saves lives but strengthens health systems and promotes broader development goals. Since the start of the epidemic, 26.9 ...

Lenacapavir offers twice-yearly HIV prevention with near-complete protection in clinical trials. Clinical trials show ...

Preventative therapies for HIV-1 (Human Immunodeficiency Virus type 1) have made leaps and bounds over the past decade. A ...

From the first reported case of AIDS to the present, what is the history of HIV-AIDS and are there parallels to the COVID-19 ...

HIV and AIDS (acquired immunodeficiency syndrome) surveillance has shown that Filipinos who are newly diagnosed with HIV are getting younger. The DOH noted that the predominant age group has shifted ...